| View |
|
DRP-10904-03
|
Co-Amoxiclav
|
Orapen-G
|
1 g (see reverse for formulation)
|
Film-Coated Tablet
|
Antibacterial (Beta-Lactam Inhibitor)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
30 May 2024
|
17 December 2026
|
| View |
|
DRP-1127-03
|
DILOXANIDE FUROATE
|
AELOX
|
500 mg
|
Tablet
|
AMEBICIDE
|
St. Martin Pharm Lab Co.
|
Philippines
|
Renewal
|
15 September 2024
|
24 September 2029
|
| View |
|
DRP-12424-05
|
Omeprazole (as sodium monohydrate)
|
Tolpraz
|
40 mg
|
Lyophilized Powder for Injection (I.V.)
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
30 May 2024
|
04 August 2027
|
| View |
|
DRP-12601-09
|
Febuxostat
|
Quric
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Sunrise International Labs Limited
|
|
CLIDP Conversion
|
30 May 2024
|
14 September 2027
|
| View |
|
DRP-12601-10
|
Febuxostat
|
None
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Sunrise International Labs Limited
|
India
|
CLIDP Conversion
|
31 May 2024
|
14 September 2027
|
| View |
|
DRP-12894-02
|
Gliclazide
|
Diaglez-80
|
80 mg
|
Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
27 May 2024
|
25 January 2027
|
| View |
|
DRP-12894-03
|
Gliclazide
|
Diaclaz
|
80 mg
|
Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
30 May 2024
|
25 January 2027
|
| View |
|
DRP-13171-09
|
Losartan Potassium + Amlodipine (as besilate)
|
Amdozar
|
50 mg/ 5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)/Calcium Channel Blocker (Dihydropyridine derivative)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
30 May 2024
|
14 December 2027
|
| View |
|
DRP-13475-05
|
Ipratropium bromide + Salbutamol (as sulfate)
|
Nebulent
|
500 mcg/2.5 mg per 2.5 mL
|
Solution for Inhalation
|
Adrenergic in combination with anticholinergic
|
Legency Remedies Pvt. Ltd
|
India
|
CLIDP Conversion
|
30 May 2024
|
27 February 2028
|
| View |
|
DRP-13558-03
|
Lapatinib (as ditosylate monohydrate)
|
None
|
250 mg
|
Film-Coated Tablet
|
Antineoplastic Agent
|
BDR Pharmaceuticals International Pvt. Ltd.–Oncology Unit
|
India
|
CLIDP Conversion
|
28 May 2024
|
09 March 2028
|
| View |
|
DRP-13922-01
|
Amlodipine (as besilate)
|
BPCheck 10
|
10 mg
|
Tablet
|
Calcium Channel Blocker (Dihydropyridine derivative)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
30 May 2024
|
24 May 2028
|
| View |
|
DRP-14255-04
|
Metformin Hydrochloride
|
Nifromin
|
850 mg
|
Film-Coated Tablet
|
Alu/Clear PVC Blister Pack x 10's / (Box of 30's and 100's)
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
CLIDP Conversion
|
30 May 2024
|
04 August 2025
|
| View |
|
DRP-1426-14
|
Cefalexin (as Monohydrate)
|
None
|
250 mg/5 mL
|
Powder for Suspension (Strawberry Flavor)
|
Antibacterial (Cephalosporin)
|
J.M. Tolmann Laboratories, Inc.
|
India
|
CLIDP Conversion
|
31 May 2024
|
05 February 2027
|
| View |
|
DRP-14595-01
|
Acetylcysteine
|
Flumodex 600
|
600 mg
|
Powder for Oral Solution
|
Mucolytic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
30 May 2024
|
20 October 2028
|
| View |
|
DRP-14776-04
|
Norepinephrine (as bitartrate)
|
Nepriqo 8
|
2 mg / ml (8 mg /4 ml)
|
Solution for Injection (I.V. Infusion)
|
Adrenergic/ Dopaminergic Agent
|
Ultra Laboratories Private Limited
|
India
|
CLIDP Conversion
|
30 May 2024
|
03 January 2029
|
| View |
|
DRP-13816-01
|
Clindamycin (as Phosphate)
|
Godamycin IV
|
150 mg/mL (600 mg/4 mL)
|
Solution for Injection (IM/IV)
|
Antibacterial (Lincosamide)
|
North China Pharmaceutical Co., Ltd (New Preparation Branch Factory)
|
China
|
CLIDP Conversion
|
03 July 2023
|
27 July 2026
|
| View |
|
DRP-13439-01
|
Aciclovir
|
Govir
|
50 mg / g (5% w/w)
|
Cream
|
Antiviral
|
Yash Medicare Private Limited
|
India
|
CLIDP Conversion
|
12 July 2023
|
20 September 2027
|
| View |
|
DRP-11998-01
|
Aminophylline
|
Aminocare
|
25 mg/mL (250 mg/10 mL)
|
Solution for Injection (I.V.)
|
Bronchodilator (Xanthines)
|
Grand Pharmaceutical (China) Co., Ltd.
|
China
|
CLIDP Conversion
|
04 July 2023
|
13 May 2027
|
| View |
|
DRP-13711-01
|
Dopamine hydrochloride
|
Decaphen
|
40 mg/ mL (200 mg/ 5mL)
|
Solution for Injection for I.V. Infusion
|
Adrenergic and Dopaminergic Agent
|
Swiss Parenterals Ltd. (Block-B)
|
India
|
CLIDP Conversion
|
30 May 2024
|
01 February 2028
|
| View |
|
DRP-2672-17
|
Clopidogrel (as bisulfate)
|
Cloplat
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic (Platelet Aggregation Inhibitor)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
30 May 2024
|
04 January 2029
|